33.36 0.00 (0.00%)
After hours: 4:38PM EST
|Bid||33.32 x 800|
|Ask||33.34 x 800|
|Day's range||33.04 - 33.55|
|52-week range||18.95 - 36.63|
|Beta (3Y monthly)||1.63|
|PE ratio (TTM)||N/A|
|Earnings date||11 Feb 2020 - 17 Feb 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||36.73|
It is doubtless a positive to see that the Colfax Corporation (NYSE:CFX) share price has gained some 32% in the last...
Colfax Corporation (“Colfax”) (CFX), today announced that it will be presenting at Stifel’s 2019 Healthcare Conference in New York, NY, on November 20, 2019 at 2:25 pm EDT. A live presentation of this event will be available via Colfax’s website at www.colfaxcorp.com under the “Investors” section. ABOUT COLFAX CORPORATION — Colfax Corporation is a leading diversified technology company that provides orthopedic care and fabrication technology products and services to customers around the world principally under the DJO and ESAB brands.
Colfax (CFX) delivered earnings and revenue surprises of 8.70% and -0.10%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
• Achieved results at the upper end of expectations • Delivered 3.9% year-on-year sales growth in Medical Technology segment including 4.5% organic.
Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Annapolis Junction, MD, Oct. 23, 2019 -- Colfax Corporation (“Colfax”) (NYSE: CFX), today announced that it will be presenting at Baird’s 2019 Global Industrial Conference in.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Colfax (CFX) is likely to gain from opportunities in fabrication technology and orthopedic solutions businesses, buyouts, and emerging market exposure. High costs, huge debts and forex woes are dragging.
Colfax Corporation (“Colfax”) (CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the third quarter of 2019 on the morning of Thursday, October 31, 2019. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public through +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (international callers) and referencing the conference ID number 7646778 or through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section. Colfax’s financial results press release and supplemental financial information referenced on the call, if any, for the third quarter of 2019 will be available under the “Investors” section of Colfax’s website prior to the conference call.
IDEX (IEX) gains from a diversified business structure, solid product offerings, acquired assets and shareholder-friendly policies. Geopolitical uncertainties and forex woes are headwinds.
Annapolis Junction, MD, Sept. 30, 2019 -- Colfax Corporation (“Colfax”) (NYSE: CFX), a leading diversified industrial technology company, today announced it completed the sale.
Anyone researching Colfax Corporation (NYSE:CFX) might want to consider the historical volatility of the share price...
Cintas' (CTAS) first-quarter fiscal 2020 earnings to gain from solid product portfolio, enterprise resource planning system and acquired assets. Lower working days and high taxes are concerning.
Solid bidding and order activities, robust backlog and favorable North America commercial construction market likely to aid Apogee's (APOG) fiscal Q2 performance.
Atkore (ATKR) benefits from volume growth in electrical categories, product launches and acquired assets. Its stock surges year to date, outperforming industry, sector and S&P 500.
Today we'll evaluate Colfax Corporation (NYSE:CFX) to determine whether it could have potential as an investment idea...
Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses and productivity actions, and gains from acquired assets. However, rising cost of sales is a concern.
Colfax's (CFX) second-quarter 2019 results benefit from improvement in core sales and acquired assets. It provides projections, after adjusting for the pending divestment of the Air and Gas Handling segment.